Medical Tribune
CAR T cell immunotherapy, illustration

Webinar

What can Kymriah® (tisagenlecleucel) offer in the treatment landscape of r/r follicular lymphoma?

14 Dec 2023
18:00 - 19:05
online
Registration for this event is no longer possible

During the training, participants have the opportunity to ask the speakers questions via chat.

Speakers

Prof. Dr. Urban Novak
Moderator, Inselspital, Bern, Switzerland
Professor Dr. Andreas Holbro
University Hospital Basel, Switzerland
Professor Dr. med. Martin Dreyling
Medical Clinic III, University Hospital, LMU München

Program

18:00
Introductions and opening remarks
(Prof. Dr. Urban Novak)
18:05
18:25
The role of CAR-T cell therapy in r/r follicular lymphoma compared with other treatments, and tisagenlecleucel real-world experience
(Professor Dr. Andreas Holbro)
18:25
18:45
Multiple r/r follicular lymphoma subgroups benefit from tisagenlecleucel in ELARA
(Professor Dr. med. Martin Dreyling)
18:45
19:00
Expert discussion and questions from the audience
19:00
19:05
Farewell
We are able to realize this webinar thanks to the kind support of Novartis.
Novartis Logo